2026 CARRA-Arthritis Foundation Advancing Biosample Collection Award
Forecasted
Funds biosample collection at CARRA sites to support translational research in pediatric rheumatic diseases, emphasizing precision medicine and critical research priorities.
Browse similar grants
Funder: Childhood Arthritis and Rheumatology Research Alliance
Due Dates (Anticipated): January 2027: Letter of Intent | January 2027: Data and Sample Share Request | March 2027: Full Application
Funding Amounts: Up to $50,000 per award for a 2-year project; typically 2 awards per cycle (at least 1 for JIA).
Summary: Supports biosample collection at CARRA Registry sites to advance translational research in pediatric rheumatic diseases, with emphasis on precision medicine and critical research priorities.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
Description
This grant supports the collection of biosamples from patients enrolled in the CARRA Registry to enable hypothesis-driven, translational research in pediatric rheumatic diseases. The program funds biosample collection at CARRA Registry sites using standardized kits, ensuring high-quality and comparable samples for future research. Projects must align with the 2023–2025 CARRA-Arthritis Foundation Inflammatory Arthritis Research Agenda, with priority given to topics such as precision medicine, biomarker identification, medication impact, genetic and environmental influences, long-term outcomes, health disparities, and treatment safety. Collected samples are stored in designated biobanks and made available for future research within the CARRA network.
